Cancer Genomics and Tumor Immunotherapy Symposium 2017
Friday, November 17, 2017; Toronto MaRS Discovery District, Toronto, Ontario
The Tumor Immunotherapy Symposium: A Clinical Perspective is a key educational event organized by the Tumor Immunotherapy Program (TIP) and the Cancer Genomics Program (CGP) at the Princess Margaret Cancer Centre. The objective is to provide academic and community oncologists, pharmaceutical leaders, regulatory agencies, basic and translational scientists and trainees with a clinical and translational perspective on genomics and immunotherapy as it applies to precision cancer medicine at the point of care. International, national, and local speakers will educate participants on emerging therapies and technologies, novel genomic approaches for diagnosis, the clinical development of tumor-derived DNA as a biomarker for cancer, immunogenomic-based drug development, response and resistance mechanisms to immune checkpoint therapy, and precision oncology for young people.
For more information, please visit http://www.pm-genomics-io-symposium.ca